Mark R. Garbrecht, Ph.D.

Jeanne Snyder	grad student	2006	University of Iowa
(11-beta hydroxysteroid dehydrogenase type 2 in the human lung and the regulation of SP-A by dexamethasone metabolites.)

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Garbrecht MR, Lamb FS. (2013) Placental HSD2 Expression and Activity Is Unaffected by Maternal Protein Consumption or Gender in C57BL/6 Mice. Isrn Endocrinology. 2013: 867938
Garbrecht MR, Schmidt TJ. (2013) Expression and Regulation of 11- β Hydroxysteroid Dehydrogenase Type 2 Enzyme Activity in the Glucocorticoid-Sensitive CEM-C7 Human Leukemic Cell Line. Isrn Oncology. 2013: 245246
Garbrecht MR, Klein JM, McCarthy TA, et al. (2007) 11-Beta hydroxysteroid dehydrogenase type 2 in human adult and fetal lung and its regulation by sex steroids. Pediatric Research. 62: 26-31
Garbrecht MR, Krozowski ZS, Snyder JM, et al. (2006) Reduction of glucocorticoid receptor ligand binding by the 11-beta hydroxysteroid dehydrogenase type 2 inhibitor, Thiram. Steroids. 71: 895-901
Garbrecht MR, Schmidt TJ, Krozowski ZS, et al. (2006) 11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites. American Journal of Physiology. Endocrinology and Metabolism. 290: E653-60
Garbrecht MR, Klein JM, Schmidt TJ, et al. (2006) Glucocorticoid metabolism in the human fetal lung: implications for lung development and the pulmonary surfactant system. Biology of the Neonate. 89: 109-19